The 2025-2030 World Outlook for Omeprazole - Image 1

Out of stock

This item is currently unavailable

The 2025-2030 World Outlook for Omeprazole

Subjects

Out of stock

Price data last checked 34 day(s) ago - refreshing...

View at Amazon

One email. No newsletter. No nudges.

Gone for 34 days. Could come back at any time — we're watching for you.

Out of stock 34 days · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No price data yet

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

This study covers the world outlook for omeprazole across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of omeprazole as including all commonly understood products falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Allergan, Amneal Pharmaceuticals, Apotex, AstraZeneca, Dr. Reddy’s Laboratories, Mylan N.V. (NASDAQ: MYL), Perrigo Company, Salix Pharmaceuticals, and Sandoz International. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).

Product Specifications

Format: paperback
ASIN: B0D15L6SPF
Category: Books > Subjects
Domain: Amazon UK
Release Date: 03 March 2024
Listed Since: 12 May 2024

The 2025-2030 World Outlook for Omeprazole

Gone for 34 days. Could come back at any time — we're watching for you.

Price History & Forecast

Price Distribution

Description

Product Specifications

Similar Products You Might Like

Pyrocalm Control 20mg Gastro-Resistant Tablets - 14 Tablets

Esomeprazole 20mg - 24-Hour Acid Reducer Capsules (14 Count)

Nexium Control 20mg Esomeprazole Heartburn Tablets - 7 Pack

Esomeprazole 20mg Delayed-Release Capsules - Acid Reflux Relief

Nexium Control Esomeprazole 20mg - 14 Heartburn Tablets

Esomeprazole 20mg - 24-Hour Acid Reducer, 14 Count

Nexium Control 20mg Esomeprazole Heartburn Relief - 14 Capsules

Gaviscon Guardium Esomeprazole 20mg - 14 Acid Reflux Tablets

Proton Pump Inhibitors (Milestones in Drug Therapy)

Interaction of Mycophenolic Acid and Pantoprazole: A Pharmacokinetic Crossover Study

Nexiumm Heartburn Relief Tablets - 28 Count (2 Packs)

Drug Development: Molecular Targets for GI Diseases

Biovita Esomeprazole 20mg - 14 Capsules Heartburn Relief

Gaviscon Advance Aniseed 250ml - Reflux Suppressant Liquid

Gaviscon Double Action Mint - 12 x 10ml Sachets for Heartburn Relief

Rennie Peppermint Antacid Tablets - 384 Pack Heartburn Relief

Healthspan Gastrisoothe Heartburn Relief - 24 Sachets, Aloe Vera

Gaviscon Double Action Liquid 150ml - Mixed Berry Heartburn Relief

TUMS Chewy Bites Antacid - Assorted Berries 60 Count

Gaviscon Double Action Mint - 96 Chewable Tablets

The 2026-2031 World Outlook for High Potency APIs (HPAPIs)

Rennie Antacids Spearmint - 384 Tablets Heartburn Relief

Gaviscon Double Action Mixed Berries - 48 Chewable Tablets

Gaviscon Double Action Mint - 24 Chewable Tablets for Heartburn